Updates are available Correction dated 2023-05-11
Click to view Correction: https://doi.org/10.1186/s40659-023-00433-6
-
Authors
Jiménez-Dinamarca, Ivanka
Prado, Yolanda
Tapia, Pablo
Gatica, Sebastian
Alt, Clemens
Lin, Charles P.
Reyes-Martínez, Cristian
Feijóo, Carmen G.
Aravena, Cristobal
González-Canacer, Alejandra
Correa, Simón
Varela, Diego
Cabello-Verrugio, Claudio
Simon, Felipe http://orcid.org/0000-0002-2653-9798
-
Funding
Funding for this research was provided by:
Fondo Nacional de Desarrollo Científico y Tecnológico (1201039, 1210903, 1210881, 1200944)
Instituto Milenio en Inmunología e Inmunoterapia (ICN 2021_045)
MiNICAD (NCN19_168)
CEDENNA (AFB180001)
NIH (NS099431)
- License Information
-
More Information
Article History
Received: 26 October 2022
Accepted: 13 February 2023
First Online: 3 March 2023
Change Date: 11 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40659-023-00433-6
Declarations
:
: The experimental protocols were approved by: the Institutional Animal Care and Use Committee of Massachusetts General Hospital (N° 2009N000085), Commission of Bioethics and Biosafety of Universidad Andres Bello (N° 004/2021 and N°002/2020), HLF institutional Ethics and Bioethics Review Board (N°141008). Patients signed an informed consent document. The investigation conforms with the principles outlined in the Declaration of Helsinki.
: The authors declare their consent for this publication.
: The authors declare that they have no competing interests.
